PlasmonicTron Co. Ltd.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
Currently focused on retinal organoid development, providing:
Retinal organoid samples suitable for bulk production
Quality validation reports including structural metrics
Retinal organoid samples suitable for bulk production
Quality validation reports including structural metrics
Founded Year
2020
Unified Business No.
83464716
Status
Active
Number of Employees
0
Total Paid-in
Capital
23,210,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
PlasmonicTron provides the critical biological infrastructure—industrial-scale Organoids—to power the next decade of biotech innovation and Regenerative Medicine. We solve the industry's primary bottleneck: achieving high-consistency and reliability in organoid bioprocessing. By integrating ML-driven process control and automated cultivation, we transform manual workflows into standardized, regulatory-grade manufacturing. From NAMs-aligned drug screening to advanced scaffolds for regenerative therapies, PlasmonicTron is the industrialized total solution for biopharma and clinical partners seeking to scale biological models and accelerate the future of precision medicine.
